Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Zoster

P-D-Arabinofuranosylcytosine [147-94-4] (ara-C, 16), C H N O, reportedly has had significant therapeutic effects in patients with localized herpes zoster, herpes eye infections, and herpes encephaUtis (33), although several negative results have also been reported (34) (Fig. 2). Ara-C, also known as cytarabine, is quite toxic and is only recommended for very severe viral infections. It is rapidly deaminated in humans to the relatively inactive ara-U Ara-C is converted in the cell to the 5 -monophosphate by deoxycytidine kinase, followed by formation of the corresponding di- and triphosphate. The triphosphate has been shown to inhibit DNA polymerase. [Pg.305]

Neuropathic pain is initiated or caused by a primary lesion in the peripheral or central nervous system. The causative agent may be trauma, nerve-invading cancer, herpes zoster, HIV, stroke, diabetes, alcohol or other toxic substances. Neuropathic pain is refractory to most analgesic drugs. Altered sodium channel activity is characteristics of neuropathic pain states. [Pg.829]

Varizella zoster vitus (VZV) is a highly contagious herpesvirus causing chickenpox upon primary infection. After recovery, the vims stays dormant in nerve roots. Weakening of the immune system, e.g. in people over the age of 60 or under immunosuppressive therapy, can lead to reactivation of VZV. This recurrence causes shingles (herpes zoster), a painful rash that develops in a well-defined band corresponding to the area enervated by the affected nerve cells. [Pg.1269]

Herpes zoster (shingles) is caused by the varicella (chickenpox) virus. It is highly contagious. The virus causes chickenpox in the child and is easily spread via the respiratory system. Recovery from childhood chickenpox results in the infection lying dormant in the nerve cells. The virus may become reactivated later in life as the older adult s immune system... [Pg.120]

Ms. Jenkins, age 77 years, has herpes zoster. The primary health care provider prescribes acyclovir 200 mg every 4 hours while awake Discuss what information you wouldgive Ms. Jmkins concerning herpes zoster, the drug regimen, and the possible adverse reactions. [Pg.127]

Severe acute and chronic allergic and inflammatory processes, keratitis, allergic corneal marginal ulcers, herpes zoster of the eye, iritis, iridocyclitis, chorioretinitis, diffuse posterior uveitis, optic neuritis, sympathetic ophthalmia, anterior segment inflammation... [Pg.516]

These drugp possess anti-inflammatory activity and are used for inflammatory conditions, such as allergic conjunctivitis, keratitis, herpes zoster keratitis, and inflammation of the iris. Corticosteroids also may be used after injury to the cornea or after corneal transplants to prevent rejection. [Pg.625]

Another topical anesthetic, similar to benzocaine, is lidocaine, which is used to relieve the pain of shingles (herpes zoster) infections. Lidocaine is called an amide anesthetic, because it is not an ester (the alcohol is replaced by an amide, the nitrogen group). Amide anesthetics are metabolized by the liver, and are less prone to cause allergic reactions. If an anesthetic has the letter i in the prefix (lidocaine, prilocaine, bupivacaine), it is an amide anesthetic. [Pg.173]

In advanced AIDS, MM is usually associated with opportunistic infections such as CMV (Said et al. 1991 RouUet et al. 1994 Kolson and Gonzalez-Scarano 2001) or is secondary to lymphoma (Fuller et al. 1993). Despite a role for other herpes viruses in AIDS-associated myelitis, no substantive evidence has been published in support of a role for other vimses in the development of HIV-associated MM, including herpes simplex 1 or 2, varicella zoster, or Epstein Barr vims (Kolson and Gonzalez-Scarano 2001). MM can occur secondary to hepatitis B and C viruses, which are common co-infections of HIV-infected patients, particularly when there is an associated cryoglobulinemia (Taillan et al. 1993 Caniatti et al. 1996). Rarely... [Pg.59]

Acyclovir (aciclovir) Famciclovir r Herpes simplex and varicella zoster... [Pg.124]

Varicella/zoster ELISA in paralled with a standard varicella-zoster immunoglobulin Not less than lOOlUmh ... [Pg.319]

Association of Pain, neuropathic pain is defined as pain initiated or caused by a primary lesion, dysfunction in the nervous system". Neuropathy can be divided broadly into peripheral and central neuropathic pain, depending on whether the primary lesion or dysfunction is situated in the peripheral or central nervous system. In the periphery, neuropathic pain can result from disease or inflammatory states that affect peripheral nerves (e.g. diabetes mellitus, herpes zoster, HIV) or alternatively due to neuroma formation (amputation, nerve transection), nerve compression (e.g. tumours, entrapment) or other injuries (e.g. nerve crush, trauma). Central pain syndromes, on the other hand, result from alterations in different regions of the brain or the spinal cord. Examples include tumour or trauma affecting particular CNS structures (e.g. brainstem and thalamus) or spinal cord injury. Both the symptoms and origins of neuropathic pain are extremely diverse. Due to this variability, neuropathic pain syndromes are often difficult to treat. Some of the clinical symptoms associated with this condition include spontaneous pain, tactile allodynia (touch-evoked pain), hyperalgesia (enhanced responses to a painful stimulus) and sensory deficits. [Pg.459]

Chest-wall injury (e.g., surgery, herpes zoster)... [Pg.714]

Dysfunction may be caused by aging, systemic inflammatory diseases, a decrease in androgen hormones, surgery, ocular surface diseases (such as herpes zoster), systemic diseases, or medications that affect the efferent cholinergic nerves. Decreased tear secretion produces an inflammatory response on the ocular surface called keratoconjunctivitis sicca. This inflammation is now a target for new medications that treat dry eye.29,30... [Pg.945]

Viruses are a common cause of CAP in children (-65%) and much less common in adults ( 15%).8 Viruses often associated with pneumonia in adults include influenza A and B and adenoviruses, whereas less common causes include rhinoviruses, enteroviruses, cytomegalovirus, varicella-zoster virus, herpes simplex virus, and others. In children, viral pneumonia is caused more commonly by respiratory syncyntial virus, influenza A virus, and parainfluenza virus. The viruses associated with CAP in adults are much less common causes of pneumonia in children. [Pg.1050]

Later in life, approximately 15% of the population will develop herpes zoster. Herpes zoster is the reactivation of latent varicella zoster virus in the sensory ganglia. Approximately 20% of persons with herpes zoster will develop post-herpetic neuralgia, which is a painful debilitating condition that can persist for months after resolution of the herpes zoster rash. [Pg.1246]

The varicella vaccine is relatively new and has only been recommended for use since 1996, therefore its true impact on chickenpox and herpes zoster is not yet known. Its continued use will undoubtedly change the epidemiology of these diseases. [Pg.1246]

The varicella vaccine is made up of an attenuated Oka strain of varicella zoster virus. This is a live attenuated vaccine. Attenuation was achieved by performing serial passages through human embryonic lung cells, embryonic guinea pig cells, and human diploid cells. [Pg.1246]

Children less than 12 years of age will have a 97% seroconversion rate following a single vaccination. Adolescents and adults more than 13 years old will only have 78% seroconversion after a single inoculation, but will have 99% conversion after the second vaccination administered 4 to 8 weeks after the first. Antibody titers appear to persist for at least 20 years following immunization. Despite excellent seroconversion rates, breakthrough chickenpox is reported at a rate of 1 case per 10,000 doses distributed. Most cases occurred within the first year following vaccination, and were due to wild-type varicella zoster virus. The majority of breakthrough cases were mild and of short duration.12... [Pg.1247]


See other pages where Zoster is mentioned: [Pg.471]    [Pg.535]    [Pg.303]    [Pg.306]    [Pg.307]    [Pg.153]    [Pg.197]    [Pg.199]    [Pg.267]    [Pg.1269]    [Pg.1313]    [Pg.1505]    [Pg.120]    [Pg.120]    [Pg.120]    [Pg.121]    [Pg.121]    [Pg.122]    [Pg.255]    [Pg.55]    [Pg.55]    [Pg.55]    [Pg.65]    [Pg.163]    [Pg.246]    [Pg.138]    [Pg.321]    [Pg.129]    [Pg.941]    [Pg.1045]    [Pg.1246]   
See also in sourсe #XX -- [ Pg.245 , Pg.250 , Pg.251 ]




SEARCH



Aciclovir varicella-zoster virus

Antiviral agent for herpes zoster ophthalmicus

Herpes Zoster trials

Herpes zoster

Herpes zoster , vaccines

Herpes zoster infection

Herpes zoster ophthalmicus

Herpes zoster vaccination

Herpes zoster virus

Herpes zoster, disseminated

Herpes zoster, with AIDS

Immunization, varicella zoster

Immunocompromised patients herpes zoster infections

Ophthalmic herpes zoster

Valacyclovir as herpes zoster treatment

Varicella zoster

Varicella zoster immunoglobulin

Varicella zoster infection

Varicella zoster vaccine

Varicella zoster virus infection

Varicella-Zoster virus cause

Varicella-Zoster virus toxicity

Varicella-zoster hepatitis

Varicella-zoster immune globulin

Varicella-zoster virus

Varicella-zoster virus acyclovir

Varicella-zoster virus cidofovir

Varicella-zoster virus infection acyclovir

Varicella-zoster virus infection drugs used

Varicella-zoster virus infection treatment

Varicella-zoster virus infection vidarabine

Varicella-zoster virus vaccine

Varicella-zoster virus vidarabine

Varicella-zoster virus, treatment

Viral DNA polymers for varicella-zoster virus

Viral infection varicella zoster

Viral keratitis herpes zoster

Zoster vaccine, live

© 2024 chempedia.info